This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cheng, K.-h. Articles by Thiagalingam, S. Search for Related Content PubMed PubMed Citation Articles by Cheng, K.-h. Articles by Thiagalingam, S.

Elucidation of Epigenetic Inactivation of SMAD8 in Cancer Using Targeted Expressed Gene Display

Departments of ¹ Medicine (Genetics Program, Pulmonary Center and Cancer Research Center), ² Pathology and Laboratory Medicine, and ³ Genetics and Genomics, Boston University School of Medicine, Boston, Massachusetts

To address the challenge of identifying related members of a large family of genes, their variants and their patterns of expression, we have developed a novel technique known as targeted expressed gene display. Here, we demonstrate the general application of this technique by analyzing the SMAD genes and report that the loss of SMAD8 expression is associated with multiple types of cancers, including 31% of both breast and colon cancers. Epigenetic silencing of SMAD8 expression by DNA hypermethylation in cancers directly correlates with loss of SMAD8 expression. The SMAD8 alteration in a third of breast and colon cancers makes it a significant novel tumor marker as well as a potential therapeutic target. The utility of targeted expressed gene display for the analysis of highly homologous gene families as demonstrated by its application to the SMAD genes suggests that it is an efficient tool for the identification of novel members, simultaneous analysis of differential expression patterns, and initial discovery of alterations of expressed genes.

This article has been cited by other articles:

				M Shintani, H Yagi, T Nakayama, T Saji, and R Matsuoka A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension J. Med. Genet., May 1, 2009; 46(5): 331 - 337. [Abstract] [Full Text] [PDF]

				S. A. Pangas, X. Li, L. Umans, A. Zwijsen, D. Huylebroeck, C. Gutierrez, D. Wang, J. F. Martin, S. P. Jamin, R. R. Behringer, et al. Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in Mice Mol. Cell. Biol., January 1, 2008; 28(1): 248 - 257. [Abstract] [Full Text] [PDF]

				R. A. Hinshelwood, L. I. Huschtscha, J. Melki, C. Stirzaker, A. Abdipranoto, B. Vissel, T. Ravasi, C. A. Wells, D. A. Hume, R. R. Reddel, et al. Concordant Epigenetic Silencing of Transforming Growth Factor- Signaling Pathway Genes Occurs Early in Breast Carcinogenesis Cancer Res., December 15, 2007; 67(24): 11517 - 11527. [Abstract] [Full Text] [PDF]

				H. M. Abdolmaleky, K.-h. Cheng, S. V. Faraone, M. Wilcox, S. J. Glatt, F. Gao, C. L. Smith, R. Shafa, B. Aeali, J. Carnevale, et al. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder Hum. Mol. Genet., November 1, 2006; 15(21): 3132 - 3145. [Abstract] [Full Text] [PDF]